Literature DB >> 14570816

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study.

Jens Wuerfel1, Judith Bellmann-Strobl, Peter Brunecker, Orhan Aktas, Henry McFarland, Arno Villringer, Frauke Zipp.   

Abstract

New MRI techniques such as the analysis of magnetization transfer or diffusion have provided evidence for subtle progressive alterations in tissue integrity prior to focal leakage of the blood-brain barrier (BBB) as part of plaque formation in multiple sclerosis. Since inflammation is capable of modulating the microcirculation, we investigated the hypothesis that changes in the local perfusion might be one of the earliest signs of lesion development. 20 patients with definite relapsing-remitting multiple sclerosis were analysed with regard to cerebral blood volume, cerebral blood flow, mean transit time and apparent diffusion coefficient (ADC), as well as conventional MRI parameters, on monthly follow-up scans. Among 89 gadolinium-enhancing lesions, we selected 18 that developed during the study and met strict inclusion criteria. In these, changes of perfusion parameters were detectable not only prior to the BBB breakdown, but also prior to increases in the ADC. Our data indicate that inflammation is accompanied by altered local perfusion, which can be detected prior to permeability of the BBB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570816     DOI: 10.1093/brain/awh007

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  71 in total

1.  The problems and promises of research into human immunology and autoimmune disease.

Authors:  Bart O Roep; Jane Buckner; Stephen Sawcer; Rene Toes; Frauke Zipp
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

2.  Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.

Authors:  Yulin Ge; Meng Law; Glyn Johnson; Joseph Herbert; James S Babb; Lois J Mannon; Robert I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

3.  Ischemia and multiple sclerosis: perfusion MR imaging provides insight into an underexplored pathophysiology.

Authors:  Jack Simon
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

Review 4.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

5.  Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.

Authors:  Sumita Adhya; Glyn Johnson; Joseph Herbert; Hina Jaggi; James S Babb; Robert I Grossman; Matilde Inglese
Journal:  Neuroimage       Date:  2006-09-22       Impact factor: 6.556

6.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Authors:  Christina Marik; Paul A Felts; Jan Bauer; Hans Lassmann; Kenneth J Smith
Journal:  Brain       Date:  2007-11       Impact factor: 13.501

Review 7.  CCSVI and MS: no meaning, no fact.

Authors:  Claudio Baracchini; Matteo Atzori; Paolo Gallo
Journal:  Neurol Sci       Date:  2012-05-09       Impact factor: 3.307

8.  Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.

Authors:  Zsolt Mezei; Laszlo Olah; Laszlo Kardos; Reka Katalin Kovacs; Laszlo Csiba; Tunde Csepany
Journal:  J Neurol       Date:  2013-06-12       Impact factor: 4.849

9.  Multiple sclerosis, blood flow, and CSF circulation.

Authors:  Jens Wuerfel
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-19       Impact factor: 6.200

10.  Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.

Authors:  Denis Peruzzo; Marco Castellaro; Massimiliano Calabrese; Elisa Veronese; Francesca Rinaldi; Valentina Bernardi; Alice Favaretto; Paolo Gallo; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.